Page 64 - Read Online
P. 64

Kim et al. Soft Sci. 2026, 6, 26                                                   Page 5 of 9





               Subsequent advances extended hybrid sensing platforms toward clinically relevant hemodynamic and
               metabolic endpoints. An epidermal patch integrating ultrasonic transducers for blood pressure and heart rate
               with electrochemical sensors for glucose, lactate, caffeine, and alcohol, demonstrated simultaneous
               monitoring of cardiovascular and biochemical dynamics during daily activities . Such combined
                                                                                         [38]
               monitoring is particularly relevant for older adults, where dehydration, infection, medication intake, or
               metabolic imbalance often manifests as coordinated rather than isolated changes in a single parameter.

               Hybrid sensing has also diversified into unobtrusive form factors optimized for long-term adherence.
               Accordingly, different wearable form factors can be employed depending on the anatomical locations best
               suited for acquiring specific physiological signals. For example, the ear offers a rich source of brain and body
               biosignals towards continuous cognitive and metabolic health monitoring. An in-ear multimodal sensor,
               integrating brain electrophysiology with electrochemical lactate sensing, enabled continuous assessment of
               neurophysiological state alongside metabolic dynamics in real-world settings . When combined with
                                                                                    [39]
               stimulation mechanisms, such systems open opportunities for personalized neurotherapeutic strategies .
                                                                                                        [40]
               This brain–body integration is particularly compelling in geriatric care, where cognitive decline and
               metabolic dysregulation frequently co-evolve.

               Wrist-worn and minimally invasive hybrid platforms further extend multimodal monitoring for chronic
               disease management. A flexible wristband integrating microneedle-based interstitial sensing with
               cardiovascular monitoring enabled simultaneous metabolic and hemodynamic tracking in individuals with
               diabetes , addressing limitations of single-parameter glucose monitoring in multimorbid older adults.
                     [41]

               Finally, advances in sweat interfacing and microfluidics have improved the reliability of biochemical sensing
               in hybrid systems. A bioinspired microfluidic wearable enabled multiday, multiplexed metabolic monitoring
               under low-sweat conditions , providing infrastructure for hybrid integration.
                                      [42]
               Collectively, these studies demonstrate a shift from isolated wearable measurements to integrated chem–phys
               platforms for longitudinal monitoring. In geriatric populations, hybrid wearables improve interpretability
               and early detection beyond episodic care.

               POTENTIAL OF WEARABLE HYBRID PLATFORMS FOR GERIATRIC CARE
               A defining challenge in geriatric medicine is that many age-associated diseases - including neurodegenerative
               disorders, cardiometabolic dysfunction, and frailty - progress gradually and manifest as coupled changes
               across physical function, biochemical regulation, and therapeutic response during daily life. Because these
               transitions unfold continuously outside clinical settings, episodic assessments often fail to capture
               meaningful dynamics. In the perspective of continuous monitoring, unlike single-modality wearables, hybrid
               sensors simultaneously measure multiple physiological and biochemical parameters, improving the reliability
               and predictive accuracy of health assessment.


               In conditions, such as Parkinson’s disease, the symptom severity fluctuates with medication timing, activity
               level, stress, and sleep, while disease progression itself is slow and heterogeneous. Wearable hybrid platforms
               that combine motion sensing, electrophysiology, and biochemical monitoring of therapeutic drugs or
               stress-related biomarkers can capture these dynamics. By preserving ecological validity and providing high
               temporal resolution, wearable systems allow clinicians to interpret motor symptoms in the context of
               concurrent biochemical state rather than relying on sparse clinical snapshots.

               The clinical impact of hybrid sensors will depend on their capacity to support personalized and adaptive
   59   60   61   62   63   64   65   66   67   68   69